Immunotherapeutics and immunomonitoring: GTCBIO'S Fourth Annual Conference, San Diego, CA, USA, January 30-31, 2012

P. Daftarian; V. L. Perez

doi:10.1358/dof.2012.37.4.1784683

Immunotherapeutics and immunomonitoring: GTCBIO'S Fourth Annual Conference, San Diego, CA, USA, January 30-31, 2012

P. Daftarian, V. L. Perez

Research output: Contribution to journal › Article › peer-review

Abstract

GTCBio's Fourth Immunotherapeutics and Immunomonitoring conference attracted clinical immunologists, pathologists, pharmacologists and scientists from the U.S., Canada, Europe and other parts of the world to hear discussions of the most promising and cutting edge developments in the field. Experts from biotech and pharmaceutical companies and academia presented novel immune-based therapeutic and immunomonitoring technologies. Also discussed was the clinical feasibility and commercial potential of the newest data obtained from leading biomedical research laboratories.

Original language	English
Pages (from-to)	293-296
Number of pages	4
Journal	Drugs of the Future
Volume	37
Issue number	4
DOIs	https://doi.org/10.1358/dof.2012.37.4.1784683
State	Published - Apr 1 2012
Externally published	Yes

Keywords

Antibodies
Cancer
Immunomonitoring
Vaccines

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1358/dof.2012.37.4.1784683

Cite this

@article{cd45863ffb3c49e1a73c3bbac8e00140,

title = "Immunotherapeutics and immunomonitoring: GTCBIO'S Fourth Annual Conference, San Diego, CA, USA, January 30-31, 2012",

abstract = "GTCBio's Fourth Immunotherapeutics and Immunomonitoring conference attracted clinical immunologists, pathologists, pharmacologists and scientists from the U.S., Canada, Europe and other parts of the world to hear discussions of the most promising and cutting edge developments in the field. Experts from biotech and pharmaceutical companies and academia presented novel immune-based therapeutic and immunomonitoring technologies. Also discussed was the clinical feasibility and commercial potential of the newest data obtained from leading biomedical research laboratories.",

keywords = "Antibodies, Cancer, Immunomonitoring, Vaccines",

author = "P. Daftarian and Perez, {V. L.}",

year = "2012",

month = apr,

day = "1",

doi = "10.1358/dof.2012.37.4.1784683",

language = "English",

volume = "37",

pages = "293--296",

journal = "Drugs of the Future",

issn = "0377-8282",

publisher = "Prous Science",

number = "4",

}

TY - JOUR

T1 - Immunotherapeutics and immunomonitoring

T2 - GTCBIO'S Fourth Annual Conference, San Diego, CA, USA, January 30-31, 2012

AU - Daftarian, P.

AU - Perez, V. L.

PY - 2012/4/1

Y1 - 2012/4/1

N2 - GTCBio's Fourth Immunotherapeutics and Immunomonitoring conference attracted clinical immunologists, pathologists, pharmacologists and scientists from the U.S., Canada, Europe and other parts of the world to hear discussions of the most promising and cutting edge developments in the field. Experts from biotech and pharmaceutical companies and academia presented novel immune-based therapeutic and immunomonitoring technologies. Also discussed was the clinical feasibility and commercial potential of the newest data obtained from leading biomedical research laboratories.

AB - GTCBio's Fourth Immunotherapeutics and Immunomonitoring conference attracted clinical immunologists, pathologists, pharmacologists and scientists from the U.S., Canada, Europe and other parts of the world to hear discussions of the most promising and cutting edge developments in the field. Experts from biotech and pharmaceutical companies and academia presented novel immune-based therapeutic and immunomonitoring technologies. Also discussed was the clinical feasibility and commercial potential of the newest data obtained from leading biomedical research laboratories.

KW - Antibodies

KW - Cancer

KW - Immunomonitoring

KW - Vaccines

UR - http://www.scopus.com/inward/record.url?scp=84860775338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860775338&partnerID=8YFLogxK

U2 - 10.1358/dof.2012.37.4.1784683

DO - 10.1358/dof.2012.37.4.1784683

M3 - Article

VL - 37

SP - 293

EP - 296

JO - Drugs of the Future

JF - Drugs of the Future

SN - 0377-8282

IS - 4

ER -

Immunotherapeutics and immunomonitoring: GTCBIO'S Fourth Annual Conference, San Diego, CA, USA, January 30-31, 2012

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this